Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.1.02227
European Journal of Endocrinology, Vol 155, Issue 3, 429-434
Copyright © 2006 by European Society of Endocrinology
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martos-Moreno, G. A
Right arrow Articles by Argente, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martos-Moreno, G. A
Right arrow Articles by Argente, J.
CLINICAL STUDY

Normative data for adiponectin, resistin, interleukin 6, and leptin/receptor ratio in a healthy Spanish pediatric population: relationship with sex steroids

Gabriel Á Martos-Moreno, Vicente Barrios and Jesús Argente

Department of Endocrinology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Avda. Menéndez Pelayo, 65, E-28009 Madrid, Spain

(Correspondence should be addressed to J Argente; Email: argentefen{at}terra.es)


   Abstract
Top
 Abstract
Introduction
 Subjects and methods
 Results
 Discussion
 References
 
Objectives: To investigate the circulating levels of adiponectin, resistin, interleukin 6 (IL-6), and leptin/receptor ratio in healthy Spanish children throughout the different stages of pubertal development. To analyze the relationship between adipokines and sex steroid level changes during puberty.

Study design: Serum adiponectin, resistin, IL-6 levels, and leptin/receptor ratio were studied in 160 healthy Spanish children grouped according to their pubertal stage (Tanner I, 23 girls and 22 boys; Tanner II, 19 girls and 16 boys; Tanners III and IV, 21 girls and 20 boys; and Tanner V, 20 girls and 19 boys). In addition, circulating levels of sex hormone-binding globulin (SHBG) were determined in every subject, and testosterone and estradiol levels in boys and girls respectively.

Results: Adiponectin levels decreased in boys from mid puberty (P < 0.05) to become significantly lower than in girls (P < 0.001), whereas IL-6 decreased in both sexes (P < 0.05). Resistin levels and leptin/receptor ratio showed no differences between sexes or according to pubertal stage, except in adult females, who had the highest levels of both parameters (P < 0.001). Serum IL-6 levels correlated significantly (P < 0.05) with testosterone and estradiol levels (r=–0.37 and –0.42 respectively), whereas estradiol, but not testosterone, correlated with leptin/receptor ratio (r=0.59; P < 0.001). Furthermore, a positive relationship was found between SHBG and adiponectin and IL-6 (P < 0.001 and P < 0.05 respectively). In addition, a direct correlation between leptin/receptor and body mass index was found in both sexes (P < 0.001).

Conclusion: Variations in adipokine profiles throughout pubertal development appear to be related with progression of gonadal function.


   Introduction
Top
 Abstract
 Introduction
Subjects and methods
 Results
 Discussion
 References
 
White adipose tissue (WAT) is an active player in energy balance and metabolic homeostasis expressing receptors for most hormonal and neurological signals, and also synthesizing a wide variety of peptides resulting in both paracrine and endocrine actions (1, 2). These peptides have numerous central and peripheral actions, some of which are not fully understood, and mediate the integration of WAT into body homeostasis control.

Among these peptides, leptin acts as a satiety signal and stimulates energy expenditure, thus regulating body weight (3). Its levels are related with body fat mass and distribution, changing in a sex-specific fashion as puberty progresses (4), as do levels of its specific soluble receptor (5), thus modulating leptin actions (6, 7). This peptide appears to be important for puberty onset and progression (8–10).

Adiponectin, specifically produced in adipocytes, is involved in glucose and lipid metabolism, directly influencing insulin sensitivity (11). Its circulating levels are negatively correlated with body mass index (BMI) and fat content (12) and, in association with visceral obesity, postulated to be a possible marker of metabolic syndrome risk (12). Adiponectin levels become significantly different between the sexes in early adulthood, suggesting that pubertal development influences adiponectin levels (13).

Circulating resistin, mainly produced by mono-nuclear cells in the adipose tissue matrix, has been positively associated with fat mass and insulin resistance (14,15), as well as interleukin 6 (IL-6) (16); however, its role in humans is controversial and sparse data regarding its levels during pubertal development are available to date.

Hence, situations modifying body fat content and distribution or specific metabolic requirements that involve adipose tissue could theoretically cause changes in adipokine profiles. During pubertal development, energy requirements necessary for the pubertal growth spurt, as well as the increase in fat mass deposits, increase (17). In addition, these fat mass deposits have a sex-specific distribution (17, 18), with increasing visceral fat accumulation in males, which could be involved in changes in adipokine secretion (19). These changes are influenced by increasing sex steroid and decreasing sex hormone-binding globulin (SHBG) levels, and thus increased bioavailability, as puberty progresses (19).

The parallel increase in fat mass and sex steroid levels during puberty could play an important role in the evolution of adipokine profiles throughout development in children and adolescents. Therefore, the aims of this study were to determine the normative data for adiponectin, resistin, and IL-6 levels and the leptin/receptor ratio in childhood and throughout the pubertal development, as well as to analyze the possible role of sex steroids in their changes.


   Subjects and methods
Top
 Abstract
 Introduction
 Subjects and methods
Results
 Discussion
 References
 
Subjects

One hundred and sixty healthy children and adolescents (83 girls (F) and 77 boys (M)) were included. They were divided into four groups according to the degree of their pubertal development: prepubertal (Tanner I) 23 F and 22 M; puberty onset (Tanner II) 19 F and 16 M; mid puberty (Tanners III and IV) 21 F and 20 M and early adults (Tanner V) 20 F and 19 M.

These children were referred to our department for suspected endocrine abnormalities and were found to be normal, with no auxological, clinical or analytical abnormalities. Their height, weight, and BMI were between ± 1 SDS according to Spanish standards (20). Their mean BMI was 0.09 ± 0.08 SDS, mean height –0.21 ± 0.11 SDS and mean weight –0.15 ± 0.09 SDS. Their mean age was 8.16 ± 0.45 years for prepubertal children; 10.65 ± 0.31 and 12.22 ± 0.39 at puberty onset for F and M respectively; 11.99 ± 0.35 (F) and 13.86 ± 0.39 (M) at mid puberty and 17.22 ± 0.41 (F) and 17.67 ± 0.52 (M) for young adults. All blood samples were obtained after overnight fasting, centrifuged, and the serum stored at –80 ° C until assayed.

All patients and their parents or guardians were informed about the purpose of the study and gave informed consent as required by the local ethics committee, which had previously approved the study.

Biochemical measurements

Serum adiponectin and testosterone were measured by commercial RIA (LINCO Research, Inc., St Charles, MO, USA and DSL, Webster, TX, USA respectively). Leptin was measured by RIA as previously reported (4). Soluble leptin receptor and resistin levels were determined by commercial ELISA assays (BioVendor Laboratory Medicine, Inc., Brno, Czech Republic and LINCO Research, Inc. respectively). Ultrasensitive ELISA assays were used to quantify circulating IL-6 (Quantikine HS, R&D Systems, Inc., Minneapolis, MN, USA) and estradiol levels (DSL). IRMA was used to determine SHBG levels (DSL). Intra- and inter-assay coefficients of variation were below 10% for all assays.

Statistical analysis

All data are reported as mean ± S.D. Analysis was performed by one-way ANOVA for comparisons between different pubertal stages and a two-tailed Student’s t-test was used for comparisons between sexes. The relationship between different quantitative variables was determined by linear regression analysis. A value of P < 0.05 was chosen as the level of significance. Statistical analyses were performed using SPSS 12.0 software for Windows (MapInfo Corporation, Troy, NY, USA).


   Results
Top
 Abstract
 Introduction
 Subjects and methods
 Results
Discussion
 References
 
Adiponectin, resistin, IL-6, and leptin/receptor ratio

Serum adiponectin levels showed no differences between the sexes in prepubertal children. Values did not change during puberty in girls, whereas in boys there was a significant decrease at mid puberty (P < 0.05), becoming significantly lower compared with girls (P < 0.001; Fig. 1AGo).


Figure 1
View larger version (17K):
[in this window]
[in a new window]
  		Figure 1 Concentrations of (A) adiponectin, (B) resistin, (C) leptin/receptor ratio, and (D) interleukin 6 (IL-6) in sera of male (•) and female ({circ}) control children grouped according to their Tanner stage. *P < 0.001 versus male; {dagger}P < 0.05; {ddagger}P < 0.001 versus previous Tanner stage. Values are reported as mean ± S.D.

 
Resistin levels and leptin/receptor ratio remained unchanged during development and showed no differences between the sexes until after puberty was completed. Both parameters were higher in Tanner V girls compared with previous stages (P < 0.001) and with Tanner V boys (P < 0.001; Fig. 1B and CGo respectively). IL-6 levels decreased in both sexes from mid puberty (P < 0.05), without any significant differences between the sexes at any pubertal stage (Fig. 1DGo).

Correlations between adipokines and BMI

A significant correlation was found between BMI and leptin/receptor ratio in both sexes (r=0.57, P < 0.001 for girls and r=0.60, P < 0.001 for boys). No significant correlation between BMI and the other adipokines studied was found.

Adipokines correlations

A significant correlation was found between resistin levels and leptin/receptor ratio when the whole cohort was analyzed together (r=0.44, P < 0.001). When this relationship was studied in males and females separately, the correlation remained in girls (r=0.54, P < 0.001), while it disappeared in boys. No other significant correlations between adipokines were found.

Correlations of sex steroids and SHBG with adipokines

Significant correlations (P < 0.05) were found between estradiol and leptin/receptor ratio (r=0.59) in girls, as well as between IL-6 and both testosterone and estradiol (r=–0.37 and –0.42 respectively; Fig. 2A and BGo). SHBG levels were positively correlated with IL-6 (r=0.3, P < 0.05; Fig. 2CGo), as well as with adiponectin (r=0.41, P < 0.001; Fig. 3Go).


Figure 2
View larger version (9K):
[in this window]
[in a new window]
  		Figure 2 Correlations between IL-6 and (A) testosterone, (B) estradiol, and (C) SHBG plasma levels in males, females, and the whole cohort respectively.

 

Figure 3
View larger version (10K):
[in this window]
[in a new window]
  		Figure 3 Correlation between adiponectin and SHBG plasma levels in the whole cohort.

 

   Discussion
Top
 Abstract
 Introduction
 Subjects and methods
 Results
 Discussion
References
 
Our results indicate that levels of circulating adipokines change during normal pubertal development in a sex-dependent fashion. Adult females have higher leptin/receptor ratio and resistin levels compared with previous pubertal stages and adult males. There is a progressive decrease in IL-6 levels in both sexes and in adiponectin levels in boys as puberty progresses. We found testosterone and estradiol levels to be inversely correlated with IL-6 levels, whereas estradiol was directly correlated with leptin/receptor ratio. In contrast, SHBG levels were directly correlated with IL-6, as well as with adiponectin levels.

We have found, consistent with our previous data (4), that leptin levels significantly increase throughout the pubertal development in females and decrease at the final stage of male puberty. It was demonstrated that leptin soluble receptor, which modulates serum leptin levels (21), decreases in both sexes after puberty onset (5), with free leptin suggested to be the active form (22). Thus, evaluation of the leptin/receptor ratio offers more valuable information than leptin levels alone. The increase in leptin bioavailability during pubertal development could be a signal to the central nervous system that metabolic conditions are adequate to undergo pubertal development (22).

The highest leptin/receptor ratio in adult females is most likely the result of changes in fat mass and sex steroid levels, as BMI and percentage and distribution of body fat seem to be the most important predictors of the leptin/receptor ratio (23). This is consistent with the correlation found between BMI and leptin/receptor ratio in our cohort overall and in both sexes when analyzed separately. Sex steroids affect this ratio through regulating the amount and distribution of fat mass and directly modulating leptin transcriptional control (24).

Adipose tissue has receptors for sex steroids (24) and testosterone exerts a negative effect on leptin transcription and secretion (25, 26), while estrogens are stimulatory (26, 27). The positive correlation found between estradiol and leptin/receptor ratio in females supports this hypothesis, whereas the lower increase of leptin/receptor ratio throughout the pubertal development in males could justify the absence of correlation with testosterone.

The lack of sex differences prior to mid puberty and the decrease in adiponectin levels found in males after mid puberty suggest that androgens could decrease adiponectin levels. Moreover, higher testosterone bioavailability in males due to the progressive decrease in SHBG throughout puberty may be involved as suggested by the direct correlation between adiponectin and SHBG levels. Indeed, plasma adiponectin levels decrease after androgen replacement in hypogonadal males (28) and experimental models (29). Moreover, adiponectin levels are also decreased in females with polycystic ovarian syndrome, who have increased testosterone levels and bioavailability, as SHBG levels are reduced (30). However, adiponectin production is also negatively correlated with visceral fat accumulation (19, 31, 32), thus the decrease in circulating adiponectin in males could also be influenced by an androgen mediated increase in visceral fat as puberty progresses (17).

Among proinflammatory cytokines, the tumoral necrosis factor {alpha} acts mainly as a local factor, whereas adipose-derived IL-6 is secreted to the bloodstream and constitutes up to one-third of circulating levels (1). Although circulating IL-6 levels in healthy infants have been reported (33), to our knowledge no information regarding IL-6 levels during pubertal development is available. Both testosterone (34) and estradiol (35) have a direct inhibitory effect on IL-6 production in humans, which is consistent with the decrease in IL-6 levels observed in both sexes after puberty onset. Likewise, IL-6 levels correlated negatively with both sex steroids and positively with SHBG levels.

We found serum resistin levels to be higher in young adult females than in males, as previously reported (36, 37). However, in agreement with most (38, 39), but not all (37) reports, we found no correlation of resistin with sex steroids or BMI. This lack of correlation is consistent with results from animal studies where estradiol did not modify plasma resistin levels (40). However, the fact that resistin levels are their highest in adult females and correlate with the leptin/receptor ratio, which does not occur in males, suggests a possible link between resistin levels and female body fat content changes. Taken together, these results might indicate a sex-specific role for adipokines in metabolic changes throughout development. Hence, the higher insulin requirements observed in late puberty could be mainly influenced by adiponectin decrease in males and resistin increase in females.

In conclusion, our findings indicate that changes in adipokine levels throughout the pubertal development are sexually dimorphic, suggesting that gonadal function progression and increasing circulating sex steroids may play an important role in adipokine changes.


   Acknowledgements
 
The authors wish to thank Dr Julie A Chowen for the critical review of the manuscript. G Á Martos-Moreno is supported by the Fondo de Investigación Sanitaria (FIS CM05/00 100). This work was supported by grants from FIS (PI040817), Comunidad de Madrid (08.5/0002/2003) and the Fundación Endocrinología y Nutrición.


   References
Top
 Abstract
 Introduction
 Subjects and methods
 Results
 Discussion
 References
 

    1. Kershaw EE & Flier JS. Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 2004 89 2548–2556.[Abstract/Free Full Text]

    2. Meier U & Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clinical Chemistry 2004 50 1511–1525.[Abstract/Free Full Text]

    3. Friedman JM & Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998 395 763–770.[CrossRef][Medline]

    4. Argente J, Barrios V, Chowen JA, Sinha MK & Considine RV. Leptin plasma levels in healthy Spanish children and adolescents, children with obesity, and adolescents with anorexia nervosa and bulimia nervosa. Journal of Pediatrics 1997 131 833–838.[CrossRef][ISI][Medline]

    5. Mann DR, Johnson AO, Gimpel T & Castracane VD. Changes in circulating leptin, leptin receptor, and gonadal hormones from infancy until advanced age in humans. Journal of Clinical Endocrinology and Metabolism 2003 88 3339–3345.[Abstract/Free Full Text]

    6. Yang G, Ge H, Boucher A, Yu X & Li C. Modulation of direct leptin signaling by soluble leptin receptor. Molecular Endocrinology 2004 18 1354–1362.[Abstract/Free Full Text]

    7. Munzberg H, Bjornholm M, Bates SH & Myers MG, Jr. Leptin receptor action and mechanisms of leptin resistance. Cellular and Molecular Life Sciences 2005 62 642–652.[CrossRef][ISI][Medline]

    8. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P & Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998 392 398–401.[CrossRef][Medline]

    9. Strobel A, Issad T, Camoin L, Ozata M & Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nature Genetics 1998 18 213–215.[CrossRef][ISI][Medline]

    10. Audí L, Mantzoros CS, Vidal-Puig A, Vargas D, Gussinye M & Carrascosa A. Leptin in relation to resumption of menses in women with anorexia nervosa. Molecular Psychiatry 1998 3 544–547.[CrossRef][ISI][Medline]

    11. Lihn AS, Pedersen SB & Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obesity Reviews 2005 6 13–21.

    12. Okamoto Y, Kihara S, Funahashi T, Matsuzawa Y & Libby P. Adiponectin: a key adipocytokine in metabolic syndrome. Clinical Science (London) 2006 110 267–278.

    13. Bottner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, Keller E, Bluher M & Kiess W. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. Journal of Clinical Endocrinology and Metabolism 2004 89 4053–4061.[Abstract/Free Full Text]

    14. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerr K, Jones R, Zhu Q & Considine RV. Serum resistin (FIZZ3) protein is increased in obese humans. Journal of Clinical Endocrinology and Metabolism 2003 88 5452–5455.[Abstract/Free Full Text]

    15. Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L & Lazar MA. Regulation of fasted blood glucose by resistin. Science 2004 303 1195–1198.[Abstract/Free Full Text]

    16. Nemet D, Wang P, Funahashi T, Matsuzawa Y, Tanaka S, Engelman L & Cooper DM. Adipocytokines, body composition, and fitness in children. Pediatric Research 2003 53 148–152.[CrossRef][ISI][Medline]

    17. Rico H, Revilla M, Villa LF, Hernández ER, Álvarez de Buergo M & Villa M. Body composition in children and Tanner’s stages: a study with dual-energy X-ray absorptiometry. Metabolism 1993 42 967–970.[CrossRef][ISI][Medline]

    18. Bouchard C, Despres JP & Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocrine Reviews 1993 14 72–93.[Abstract]

    19. Wajchenberg BL, Giannella-Neto D, da Silva ME & Santos RF. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Hormone and Metabolic Research 2002 34 616–621.[CrossRef][ISI][Medline]

    20. Hernández M, Castellet J, Narvaiza JL, Rincón JM, Ruiz I & Sánchez E. Curvas y tablas de crecimiento Instituto de Investigación sobre Crecimiento y Desarrollo. Fundación Faustino Orbegozo, Madrid: Editorial Garsi, 1988.

    21. Chan JL, Bluher S, Yiannakouris N, Suchard MA, Kratzsch J & Mantzoros CS. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes 2002 51 2105–2112.[Abstract/Free Full Text]

    22. Landt M, Parvin CA & Wong M. Leptin in cerebrospinal fluid from children: correlation with plasma leptin, sexual dimorphism, and lack of protein binding. Clinical Chemistry 2000 46 854–858.[Abstract/Free Full Text]

    23. Misra M, Miller KK, Almazan C, Ramaswamy K, Aggarwal A, Herzog DB, Neubauer G, Breu J & Klibanski A. Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 2004 89 3486–3495.[Abstract/Free Full Text]

    24. Mayes JS & Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obesity Reviews 2004 5 197–216.

    25. Casabiell X, Pineiro V, Vega F, De La Cruz LF, Dieguez C & Casanueva FF. Leptin, reproduction and sex steroids. Pituitary 2001 4 93–99.[CrossRef][Medline]

    26. Wabitsch M, Blum WF, Muche R, Braun M, Hube F, Rascher W, Heinze E, Teller W & Hauner H. Contribution of androgens to the gender difference in leptin production in obese children and adolescents. Journal of Clinical Investigation 1997 100 808–813.[ISI][Medline]

    27. Kratzsch J, Lammert A, Bottner A, Seidel B, Mueller G, Thiery J, Hebebrand J & Kiess W. Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence. Journal of Clinical Endocrinology and Metabolism 2002 87 4587–4594.[Abstract/Free Full Text]

    28. Lanfranco F, Zitzmann M, Simoni M & Nieschlag E. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clinical Endocrinology (Oxford) 2004 60 500–507.

    29. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T & Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002 51 2734–2741.[Abstract/Free Full Text]

    30. Sieminska L, Marek B, Kos-Kudla B, Niedziolka D, Kajdaniuk D, Nowak M & Glogowska-Szelag J. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters. Journal of Endocrinological Investigation 2004 27 528–534.[ISI][Medline]

    31. Lee S, Bacha F, Gungor N & Arslanian SA. Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care 2006 29 51–56.[Abstract/Free Full Text]

    32. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD & Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003 46 459–469.[ISI][Medline]

    33. Berdat PA, Wehrle TJ, Kung A, Achermann F, Sutter M, Carrel TP & Nydegger UE. Age-specific analysis of normal cytokine levels in healthy infants. Clinical Chemistry and Laboratory Medicine 2003 41 1335–1339.

    34. Bellido T, Jilka RL, Boyce BF, Girasole G, Broxmeyer H, Dalrymple SA, Murray R & Manolagas SC. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. Journal of Clinical Investigation 1995 95 2886–2895.[ISI][Medline]

    35. Rachon D, Mysliwska J, Suchecka-Rachon K, Wieckiewicz J & Mysliwski A. Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women. Journal of Endocrinology 2002 172 387–395.[Abstract]

    36. Yannakoulia M, Yiannakouris N, Bluher S, Matalas AL, Klimis-Zacas D & Mantzoros CS. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. Journal of Clinical Endocrinology and Metabolism 2003 88 1730–1736.[Abstract/Free Full Text]

    37. Gerber M, Boettner A, Seidel B, Lammert A, Bar J, Schuster E, Thiery J, Kiess W & Kratzsch J. Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. Journal of Clinical Endocrinology and Metabolism 2005 90 4503–4509.[Abstract/Free Full Text]

    38. Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C & Mantzoros CS. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. Journal of Clinical Endocrinology and Metabolism 2003 88 4848–4856.[Abstract/Free Full Text]

    39. Chen CC, Li TC, Li CI, Liu CS, Wang HJ & Lin CC. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metabolism 2005 54 471–475.[ISI][Medline]

    40. Gui Y, Silha JV & Murphy LJ. Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obesity Research 2004 12 1481–1491.[ISI][Medline]

Received 21 March 2006
Accepted 12 June 2006





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martos-Moreno, G. A
Right arrow Articles by Argente, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martos-Moreno, G. A
Right arrow Articles by Argente, J.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS